Dermapharm Holding (DMP.DE) stock: key figures, P/E, revenue and dividend

Health Care · Germany · ISIN DE000A2GS5D8

Price
38.70 EUR
Market cap
2.08 bn EUR
P/E (2025)
15.74
P/S (2025)
1.79
Dividend yield
2.27 %
Net margin
11.34 %
Return on equity (ROE)
19.01 %
Return on assets (ROA)
5.99 %

Dermapharm Holding financials

Fiscal year20242025
Revenue1.18 bn EUR1.16 bn EUR
Gross profit767.00 m EUR391.00 m EUR
Operating income222.07 m EUR236.62 m EUR
EBIT216.00 m EUR221.00 m EUR
Net income113.00 m EUR132.00 m EUR
Diluted EPS – continuing operations2.11 EUR2.46 EUR

Full history since 2013, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Dermapharm Holding

Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China. The company operates through three segments: Branded Pharmaceuticals; Other Healthcare Products; and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company also provides vitamins, minerals, food supplements, as well as products for dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology. In addition, it offers cosmetics and medical devices. Further, the company imports originator pharmaceuticals under the axicorp brand. It sells its products under the Dekristol, Keltican, Tromcardin, Ketozolin, bite away, and Herpotherm brands. The company was founded in 1991 and is headquartered in Grünwald, Germany. Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-AG.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 22.10.2026. Details in the risk notice.